Even though it has been established early on in vitro and in vivo that not all CMT-related YARS1 and GARS1 mutats display a loss of aminoacylation function [19,33,34,44], it could not be excluded that they affect the translational machinery or translational regulation in a more indirect manner. The gene discussed is GARS1; the disease is Charcot-Marie-Tooth disease.